Details for Patent: 9,180,090
✉ Email this page to a colleague
Which drugs does patent 9,180,090 protect, and when does it expire?
Patent 9,180,090 protects QUZYTTIR and is included in one NDA.
This patent has five patent family members in five countries.
Summary for Patent: 9,180,090
| Title: | Non-sedating antihistamine injection formulations and methods of use thereof |
| Abstract: | Disclosed are injectable formulations of cetirizine for treating acute allergic reactions and methods for treating acute allergic reactions. In particular, an intravenous injectable is disclosed as are methods of treating acute allergic reactions. |
| Inventor(s): | Du; Jie (Lansdale, PA) |
| Assignee: | JDP THERAPEUTICS, INC. (Lansdale, PA) |
| Application Number: | 13/644,290 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 9,180,090
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jdp | QUZYTTIR | cetirizine hydrochloride | SOLUTION;INTRAVENOUS | 211415-001 | Oct 4, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF ACUTE URTICARIA | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,180,090
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2010266103 | ⤷ Sign Up | |||
| Canada | 2803987 | ⤷ Sign Up | |||
| European Patent Office | 2477634 | ⤷ Sign Up | |||
| Spain | 2616703 | ⤷ Sign Up | |||
| World Intellectual Property Organization (WIPO) | 2011003074 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
